Use of insoluble fusion proteins to purify antibodies.
Luo
J
J
Department of Pharmacology, Georgetown University School of Medicine, Washington, DC 20007, USA.
Wolfe
B B
BB
D000906:Antibodies / Q000302:isolation & purification*; D000911:Antibodies, Monoclonal / Q000276:immunology / Q000302:isolation & purification; D000918:Antibody Specificity; D015153:Blotting, Western; D002460:Cell Line; D002846:Chromatography, Affinity / Q000379:methods*; D006639:Histidine / Q000235:genetics; D016202:N-Methylaspartate / Q000235:genetics / Q000276:immunology; D010446:Peptide Fragments / Q000235:genetics / Q000276:immunology; D011993:Recombinant Fusion Proteins; D014162:Transfection
D000906:Antibodies; D000911:Antibodies, Monoclonal; D010446:Peptide Fragments; D011993:Recombinant Fusion Proteins; D006639:Histidine; D016202:N-Methylaspartate